Skip to main content

Month: September 2025

Alma íbúðafélag hf.: Árshlutareikningur 30.6.2025

Á fundi sínum í dag samþykkti stjórn Ölmu íbúðafélags hf. árshlutareikning samstæðunnar fyrir fyrri árshelming 2025.  Heildartekjur samstæðunnar námu 2.871 millj. kr., þar af voru leigutekjur 2.590 millj. kr. og aðrar rekstrartekjur 280 millj. kr. Rekstrarhagnaður fyrir matsbreytingu og afskriftir (EBITDA) nam 2.127 millj. kr. og hækkaði um 147 millj. kr. samanborið við sama tímabil í fyrra. Hagnaður tímabilsins nam 769 millj. kr. Heildareignir samstæðunnar þann 30. júní 2025 námu 114.482 millj. kr., þar af voru fjárfestingareignir að andvirði 79.661 millj. kr. og skráð hlutabréf 4.627 millj. kr. Eigið fé í lok júní 2025 var 37.627 millj. kr. Árið 2024 gerði Langisjór ehf., móðurfélag Ölmu íbúðafélags hf., yfirtökutilboð í Eik fasteignafélag hf. samkvæmt lögum nr. 108/2007 um yfirtökur og lauk því ferli 18. október 2024. Á meðal samstarfsaðila...

Continue reading

Next Technology Holding Inc. Announces $9 Million Registered Direct Offering

CHEYENNE, WY, Sept. 02, 2025 (GLOBE NEWSWIRE) — Next Technology Holding Inc. (NASDAQ: NXTT) (the “Company”), today announced that it has entered into a definitive agreement with one investor for the purchase and sale of an aggregate of 60,000,000 of the Company’s common stock, no par value (the “Shares”) (or pre-funded warrants in lieu thereof) at a purchase price of $0.15 per share in a registered direct offering. The purchase price for the pre-funded warrants is identical to the purchase price for Shares, less the exercise price of $0.001 per share. The aggregate gross proceeds to the Company of this offering are expected to be approximately $9 million. The transaction is expected to close on or about September 3, 2025, subject to the satisfaction of customary closing conditions. Univest Securities, LLC is acting as the sole...

Continue reading

Actelis Networks Announces Warrant Exercise for $1.6 Million in Gross Proceeds

FREMONT, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, announced today the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase an aggregate of 4,270,197 shares of the Company’s common stock originally issued by the Company in December 2023, June 2024 and July 2024, at original exercise prices ranging from $1.18 to $2.00 per share, at a reduced exercise price of $0.37 per share. The resale of the shares of common stock issuable upon the exercise of the existing warrants has been registered pursuant to effective registration statements on Form S-1 (File Nos. 333-276425, 333-280434 and 333-281079). In addition,...

Continue reading

Zoom wins Engineering, Science & Technology Emmy® Award for innovation in broadcast contribution

SAN JOSE, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) — The Television Academy has honored Zoom Communications, Inc. (NASDAQ: ZM) with an Engineering, Science & Technology Emmy® Award for its groundbreaking Zoom for Broadcast technology. The award recognizes innovations that have made a material impact on television engineering and broadcast storytelling and will be presented at the Television Academy’s Engineering, Science & Technology Emmy® Awards ceremony in Los Angeles on Tuesday, October 14. Zoom for Broadcast has redefined remote media contribution, enabling broadcasters, production teams, and content creators to integrate high-quality video and audio streams from remote participants anywhere in the world into professional live productions with minimal latency and maximum reliability. “We’re proud to help democratize...

Continue reading

UPDATE — NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office

NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller. Company has recently raised $8.8 million capital from experienced biotech investors with no warrants, repricing, or other variable rate features. HOPE clinics will combine treatment with neuroplastic drugs including ketamine, transcranial magnetic stimulation, and hyperbaric oxygen to treat suicidal depression, PTSD, traumatic brain injury and other forms of cognitive dysfunction. Matthew Rockefeller is announced as joining the HOPE Therapeutics Advisory Board.SOUTHAMPTON, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, presented...

Continue reading

Rexel: REXEL SUCCESSFULLY PLACES A SENIOR NOTES OFFERING FOR A NOMINAL AMOUNT OF €400 MILLION

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA REXEL SUCCESSFULLY PLACES A SENIOR NOTES OFFERING FOR A NOMINAL AMOUNT OF €400 MILLION Rexel, a worldwide expert in the multichannel professional distribution of products and services for the energy world, has successfully placed €400 million of its 4.000% unsecured senior notes due 2030 (the “Notes”). The delivery and settlement as well as the listing of the notes on the Euro MTF market of the Luxembourg Stock Exchange are expected to occur on or around September 9, 2025. The Notes, which mature on September 15, 2030, will be callable as from September 2027. They will rank pari passu with Rexel’s senior credit facility and other senior unsecured notes. The Notes are expected to obtain the following ratings: Ba1 by Moody’s (while...

Continue reading

QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health

Back-to-School Season Just Got Smarter The Pediatric Health Assessment empowers parents and providers to uncover hidden health or behavioral issues that may affect academic and social success. QHSLab’s platform delivers critical insights at the perfect time for pediatricians to support whole-child wellness as families prepare for the new academic year. West Palm Beach, FL, Sept. 02, 2025 (GLOBE NEWSWIRE) — QHSLab Inc. (the “Company”) (OTCQB: USAQ), a leading provider in digital medicine solutions for primary care and specialty practices, today announced the recent launch of its new Pediatric Health Assessment with a prominent, multi-location pediatric group in Texas. The assessment is now live across the group’s practices, aligning with the annual surge in back-to-school visits and well-child checkups. The Pediatric Health Assessment...

Continue reading

EdgeMode Signs Memorandum of Understanding to Expand Data Center and Energy Storage Capabilities in Sweden

FORT LAUDERDALE, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) — EdgeMode Inc. (OTC: EDGM), a next-generation AI data infrastructure company, today announced that it has entered into a Memorandum of Understanding (MoU) with Marviken ONE AB, a Swedish private energy infrastructure company, to expand data center and energy storage operations in Marviken, Sweden. The agreement outlines a strategic collaboration to significantly increase grid connection capacity, unlocking the next phase of large-scale AI-driven data center growth and the seamless integration of battery energy storage systems (BESS). EdgeMode currently operates data center infrastructure in Marviken and is building a robust pipeline of enterprise customers seeking scalable, energy-efficient, and resilient operations in the region. Through the collaboration, EdgeMode will work...

Continue reading

Notice regarding supplemented Valstybės investicinis kapitalas UAB unaudited financial information for the six months of 2025

Valstybės investicinis kapitalas UAB submits Unaudited Interim Financial Statements for the 6-month period ended 30 June 2025, prepared according to the International Financial Reporting Standards as adopted by the European Union. Enclosed: Interim Financial Statements of Valstybės investicinis kapitalas UAB prepared according to the International Financial Reporting Standards as adopted by the European Union for the 6-month period ended 30 June 2025 (unaudited).   SupplementAlongside the previously published financial statements for the first half of 2025, the statements of responsible persons are additionally provided. This supplement does not change the content of the financial statements.  Contact person: Vaidas DaktariunasValstybės investicinis kapitalas UAB, Chief Executive OfficerPhone: +370 618 29216E-mail: info@vika.ltAttachments...

Continue reading

Correction: Camposol Holding PLC reports Preliminary Second Quarter and First Half 2025 Results.

LIMA, Peru, September 2, 2025 — Camposol Holding PLC (Camposol or the Company), a multinational company providing fresh and healthy food globally, today announced its preliminary financial results for the second quarter ended June 30, 2025. These results have been prepared in accordance with International Financial Reporting Standards (IFRS) and are subject to change based on the issuance of the Company’s audited financial statements. Camposol Reports Net Debt-to-EBITDA Ratio of 2.59x, the Fourth Consecutive Quarter Below 3.5x Threshold. 1) First Half 2025 Financial Overview:Volume Sold: 55,162 MT, up 38% compared to 1H 2024. Sales: USD 222 million, up 22% compared to 1H 2024. EBITDA: USD 67.0 million, up 9% compared to 1H 2024. EBITDA Margin: 30%. Net Profit: USD 16.0 million, down 17% compared to 1H 2024. Net Debt/EBITDA ratio1:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.